These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4324865)

  • 21. Cyclic 3',5'-nucleotide phosphodiesterase of Serratia marcescens.
    Okabayashi T; Ide M
    Biochim Biophys Acta; 1970 Oct; 220(1):116-23. PubMed ID: 4319606
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclic 3',5'-AMP phosphodiesterase in isolated fat cells. Simple and sensitive methods for the assay of phosphodiesterase activity in fat cells and studies of the enzyme inhibition by theophylline.
    Schönhöfer PS; Skidmore IF; Bourne HR; Krishna G
    Pharmacology; 1972; 7(2):65-77. PubMed ID: 4340944
    [No Abstract]   [Full Text] [Related]  

  • 23. Biological roles for 3',5'-cyclic nucleotides. I. Lipolytic agents in isolated rat epididymal adipose cells and substrates for adipose tissue phosphodiesterase.
    Blecher M; Ro'Ane JT; Flynn PD
    Arch Biochem Biophys; 1971 Jan; 142(1):351-62. PubMed ID: 4322808
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclic nucleotide phosphodiesterase activity in man, monkey, and rat.
    Williams RH; Little SA; Beug AG; Ensinck JW
    Metabolism; 1971 Aug; 20(8):743-8. PubMed ID: 4327979
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on pyrazinoylguanidine. 4. Upregulation of phosphodiesterase activity in rat adipose tissue and downregulation of gluconeogenesis and adenosine 3',5'-monophosphate concentrations in perfused rat liver.
    A-Rahim YI; Rannels SL; Kimball SR; Beyer KH; Vesell ES
    Pharmacology; 1996 Oct; 53(4):211-8. PubMed ID: 8958559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the action of insulin in isolated adipose tissue cells. II. 3',5'-Nucleotide phosphodiesterase and antilipolysis.
    Hepp KD; Menahan LA; Wieland O; Williams RH
    Biochim Biophys Acta; 1969 Sep; 184(3):554-65. PubMed ID: 4309600
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of various antilipolytic compounds on adenyl cyclase and phosphodiesterase activity in isolated fat cells.
    Allen DO; Clark JB
    Adv Enzyme Regul; 1970; 9():99-112. PubMed ID: 4329199
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclic nucleotide phosphodiesterase in pea seedlings.
    Lin PP; Varner JE
    Biochim Biophys Acta; 1972 Aug; 276(2):454-74. PubMed ID: 4341591
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclic 3',5'-nucleotide phosphodiesterase, IV. Two enzymes with different properties from brain.
    Kakiuchi S; Yamazaki R; Teshima Y
    Biochem Biophys Res Commun; 1971 Mar; 42(5):968-74. PubMed ID: 4324840
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesterase.
    Harris DN; Chasin M; Phillips MB; Goldenberg H; Samaniego S; Hess SM
    Biochem Pharmacol; 1973 Jan; 22(2):221-8. PubMed ID: 4357795
    [No Abstract]   [Full Text] [Related]  

  • 31. Activation and inhibition of lipolysis in isolated fat cells by various inhibitors of cyclic AMP phosphodiesterase.
    Schwabe U; Berndt S; Ebert R
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):62-74. PubMed ID: 4338396
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of glucocorticoids and insulin on 3',5'-AMP phosphodiesterase activity in adrenalectomized rats.
    Senft G; Schultz G; Munske K; Hoffmann M
    Diabetologia; 1968 Dec; 4(6):330-5. PubMed ID: 4311828
    [No Abstract]   [Full Text] [Related]  

  • 33. Activity of 3',5'-AMP phosphodiesterase in liver and adipose tissue of normal and diabetic rats.
    Müller-Oerlinghausen B; Schwabe U; Hasselblatt A; Schmidt FH
    Life Sci; 1968 Jun; 7(12):593-8. PubMed ID: 4299702
    [No Abstract]   [Full Text] [Related]  

  • 34. Rat adrenal cyclic nucleotide-phosphodiesterase; inhibition by drugs known to affect steroidogenesis.
    Klotz U; Vapaatalo H; Stock K
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(4):376-85. PubMed ID: 4340534
    [No Abstract]   [Full Text] [Related]  

  • 35. The transport and metabolism of the uridine mononucleotides by rat jejunum in vitro.
    Bronk JR; Hastewell JG
    J Physiol; 1989 Jan; 408():129-35. PubMed ID: 2778724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipolytic action of 3,3'5-triiodo-L-thyronine, a cyclic AMP phosphodiesterase inhibitor.
    Mandel LR; Kuehl FA
    Biochem Biophys Res Commun; 1967 Jul; 28(1):13-8. PubMed ID: 4292872
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of cyclic 3',5'-adenosine monophosphate phosphodiesterase by substituted imidazopyrazines.
    Mandel LR
    Biochem Pharmacol; 1971 Dec; 20(12):3413-21. PubMed ID: 4332205
    [No Abstract]   [Full Text] [Related]  

  • 38. 3':5'-cyclic nucleotide phosphodiesterases in rat tissues.
    Campbell MT; Oliver IT
    Eur J Biochem; 1972 Jun; 28(1):30-7. PubMed ID: 4340478
    [No Abstract]   [Full Text] [Related]  

  • 39. [Presence and separation of plant nucleotide glucose pyrophosphorylases].
    Axelos M; Péaud-Lenoël C
    Bull Soc Chim Biol (Paris); 1969 Jun; 51(2):261-73. PubMed ID: 4308039
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on adrenocortical carcinoma of rat cyclic nucleotide phosphodiesterase activities.
    Sharma RK
    Cancer Res; 1972 Aug; 32(8):1734-6. PubMed ID: 4339750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.